Corundum Group, Inc. My Md Pharmaceuticals, Inc. Transaction History

Corundum Group, Inc.

  • $218 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 07, 2022
BUY
$5.46 - $9.69 $45,645 - $81,008
8,360 Added 74.38%
19,600 $119,000
Q2 2021

Aug 02, 2021
BUY
$3.39 - $6.98 $38,103 - $78,455
11,240 New
11,240 $71,000

Others Institutions Holding MYMD

# of Institutions
2
Shares Held
30.2K
Call Options Held
0
Put Options Held
0
View Full List

About MyMD Pharmaceuticals, Inc.

MYMD Quotes by TradingView
  • Ticker MYMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,470,000
  • Market Cap $67.5M
  • Description
  • MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and o...
More about MYMD
Track This Portfolio

Track Corundum Group, Inc. Portfolio

Follow Corundum Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Corundum Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Corundum Group, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email